NCT05597176

Brief Summary

The purpose of this research is to test the health benefits of using functional electrical stimulation for lower extremity exercise at home.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

January 13, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2025

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

2 years

First QC Date

October 24, 2022

Last Update Submit

January 27, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in percent body fat

    Percent body fat will be assessed using Dual Energy x-ray absorbency (DXA)

    Baseline, 20 weeks (Post Intervention)

  • Change in percent visceral fat

    Percent visceral fat will be assessed using DXA

    Baseline, 20 weeks (Post Intervention)

  • Change in percent of lean body mass

    Percent lean body mass will be assessed using DXA

    Baseline, 20 weeks (Post Intervention)

  • Change in percent of fat free mass

    Percent fat free mass will be assessed using DXA

    Baseline, 20 weeks (Post Intervention)

Secondary Outcomes (6)

  • Change in Lipid Panel values

    Baseline, 20 weeks (Post Intervention)

  • Change in resting metabolic rate

    Baseline, 20 weeks (Post Intervention)

  • Change in glucose levels

    Baseline, 20 weeks (Post Intervention)

  • Change in HgbA1C levels

    Baseline, 20 weeks (Post Intervention)

  • Change in Insulin levels

    Baseline, 20 weeks (Post Intervention)

  • +1 more secondary outcomes

Study Arms (1)

Spinal Cord Injury Exercise Group

EXPERIMENTAL

Participants will exercise at home 3-5 times per week under supervision via teleconference. Participants will be part of this group for 18-20 weeks.

Other: Spinal Cord Injury Exercise Group

Interventions

Participants will have an initial accommodation period of 4 weeks, during which four 10-minute exercise bouts/day will be interspersed with 5 minutes of rest. The bouts will gradually increase until at least continuous 40-minute sessions. The remaining 12-week intervention will be set at 70% max heart rate for a total of 16 weeks.

Spinal Cord Injury Exercise Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women of child-bearing potential who agree to refrain from getting pregnant during the trial
  • Previously enrolled in the SCIENCE protocol (NCT03495986) randomized to the diet alone group in SCIENCE, and are willing to complete an 8-week (2 month) washout period after the completion of the dietary intervention in the study.

You may not qualify if:

  • Those who have participated in a Functional Electrical Stimulation (FES) or ACE exercise program (\>60 minutes/week) within the past 3 months
  • Self-reported or documented history of:
  • orthopedic limitations
  • coronary artery disease
  • type 1 diabetes mellitus; insulin-requiring Type 2 diabetes mellitus; untreated Type 2 diabetes mellitus
  • untreated hypothyroidism
  • renal disease
  • uncontrolled autonomic dysreflexia, recent (within 3 months)
  • deep vein thrombosis (within the past 3 months)
  • On anticoagulation therapy
  • Pressure injuries \> Grade II
  • Decisional impairment
  • Prisoners
  • Pregnant or nursing women
  • Any potential causes of autonomic dysreflexia at the discretion of the PI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami Christine E. Lynn Rehabilitation Center

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Spinal Injuries

Condition Hierarchy (Ancestors)

Back InjuriesWounds and Injuries

Study Officials

  • Eduard Tiozzo, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

October 24, 2022

First Posted

October 27, 2022

Study Start

January 13, 2023

Primary Completion

January 24, 2025

Study Completion

January 24, 2025

Last Updated

January 28, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations